Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 July 2020 | Story Nitha Ramnath | Photo UFS photo archive

The Department of Business Management within the Faculty of Economic and Management Sciences is one of four successful recipients of the Nurturing Emerging Scholars Programme (NESP), which aims to recruit honours graduates who demonstrate academic ability and express an early interest in the possibility of an academic career. 

 “The NESP is a mechanism that addresses a potential shortcoming in the department in the medium to long term. Most of the academics in the department specialise either in entrepreneurship or marketing. As such, the availability of academics with interdisciplinary business knowledge who can teach and do research across the different sub-fields of business management is limited,” says Prof Brownhilder Neneh, Associate Professor in the Department of Business Management.

Once graduates enter the programme – as NESP master’s graduates they form part of a resource pool from which new academics can be recruited. 

Prof Neneh continues: “Considering the imminent retirement of academics in the department, the NESP provides an opportunity to recruit an academic who is able to work with experienced academics, gain experience, and ‘prepare’ the person to become an expert across the different fields in the department.”

“This programme would assist in succession planning within the department as well as training individuals within academia,” she says. 

According to Prof Neneh, access to this funding opportunity will further strengthen and expand the path that the department has embarked upon as far as striving for excellence in teaching, research, and community engagement is concerned, thereby contributing to address key societal challenges. “Appointing an NESP candidate would be an ideal opportunity to recruit an academic who will be able to work with the senior staff and gain experience and teaching/research competencies relevant to the 4IR, and ‘prepare’ the person to become the business management expert in the department,” she says.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept